Evaluation of the chorioretinal thickness changes in Alzheimer's disease using spectral-domain optical coherence tomography

Clinical and Experimental Ophthalmology

Volumn 43, Issue 2, 2015, Pages 145-151

  Bayhan, Hasan Ali ^a   Aslan Bayhan, Seray ^a   Celikbilek, Asuman ^a   Tanik, Nermin ^a   Gürdal, Canan ^a  

^a BOZOK UNIVERSITY   (Turkey)

Author keywords

Alzheimer's disease; Choroidal thickness; Ganglion cell complex; Spectral domain optical coherence tomography

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CHORIORETINAL THICKNESS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; OPTICAL COHERENCE TOMOGRAPHY DEVICE; OUTER RETINAL THICKNESS; PROSPECTIVE STUDY; RETINA GANGLION CELL; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL SYSTEM PARAMETERS; CHOROID; COMPLICATION; CROSS-SECTIONAL STUDIES; EVALUATION; HUMANS; NERVE FIBERS; ORGAN SIZE; PATHOLOGY; PROSPECTIVE STUDIES; RETINA; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE;

AGED; ALZHEIMER DISEASE; CHOROID; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; NERVE FIBERS; ORGAN SIZE; PROSPECTIVE STUDIES; RETINA; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84925969694     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12386     Document Type: Article

References (37)

1. Reitz C, Mayeux R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol 2014; 88: 640-651.
2. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010; 362: 329-344.
3. Tzekov R, Mullan M. Vision function abnormalities in Alzheimer disease. Surv Ophthalmol 2014; 59: 414-433.
4. Cronin-Golomb A, Corkin S, Rizzo JF, Cohen J, Growdon JH, Banks KS. Visual dysfunction in Alzheimer's disease: relation to normal aging. Ann Neurol 1991; 29: 41-52.
5. Morrison JH, Hof PR, Bouras C. An anatomic substrate for visual disconnection in Alzheimer's disease. Ann N Y Acad Sci 1991; 640: 36-43.
6. Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med 1986; 315: 485-487.
7. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci 2007; 48: 2285-2289.
8. Iseri PK, Altinas O, Tokay T, Yüksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 2006; 26: 18-24.
9. Müller F, O'Rahilly R. The development of the human brain from a closed neural tube at stage 13. Anat Embryol (Berl) 1988; 177: 203-224.
10. Kaarniranta K, Salminen A, Haapasalo A, Soininen H, Hiltunen M. Age-related macular degeneration (AMD): Alzheimer's disease in the eye. J Alzheimers Dis 2011; 24: 615-631.
11. Sivak JM. The aging eye: common degenerative mechanisms between the Alzheimer's brain and retinal disease. Invest Ophthalmol Vis Sci 2013; 54: 871-880.
12. Ghiso JA, Doudevski I, Ritch R, Rostagno AA. Alzheimer's disease and glaucoma: mechanistic similarities and differences. J Glaucoma 2013; 22: S36-38.
13. De la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004; 3: 184-190.
14. Ning A, Cui J, To E, Ashe KH, Matsubara J. Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci 2008; 49: 5136-5143.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
16. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn. Washington, DC: American Psychiatric Association, 1994.
17. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of the patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
18. Tan O, Chopra V, Lu AT etal. Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography. Ophthalmology 2009; 116: 2305-2314.
19. Blanks JC, Hinton DR, Sadun AA, Miller CA. Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res 1989; 501: 364-372.
20. Blanks JC, Torigoe Y, Hinton DR, Blanks RH. Retinal degeneration in the macula of patients with Alzheimer's disease. Ann N Y Acad Sci 1991; 640: 44-46.
21. Moschos MM, Markopoulos I, Chatziralli I etal. Structural and functional impairment of the retina and optic nerve in Alzheimer's disease. Curr Alzheimer Res 2012; 9: 782-788.
22. Katz B, Rimmer S, Iragui V, Katzman R. Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration? Ann Neurol 1989; 26: 221-225.
23. Nakamura T, Lipton SA. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases. Apoptosis 2010; 15: 1354-1363.
24. Oliveira LT, Louzada PR, de Mello FG, Ferreira ST. Amyloid-β decreases nitric oxide production in cultured retinal neurons: a possible mechanism for synaptic dysfunction in Alzheimer's disease? Neurochem Res 2011; 36: 163-169.
25. Koronyo-Hamaoui M, Koronyo Y, Liubimov AV etal. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 2011; 54: S204-217.
26. McKee AC, Au R, Cabral HJ etal. Visual association pathology in preclinical Alzheimer disease. J Neuropathol Exp Neurol 2006; 65: 621-630.
27. Guo L, Duggan J, Corderio MF. Alzheimer's disease and retinal neurodegeneration. Curr Alzheimer Res 2010; 7: 3-14.
28. Kesler A, Vakhapova V, Korczyn AD, Naftaliev E, Neudorfer M. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg 2011; 113: 523-526.
29. Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2007; 420: 97-99.
30. Marziani E, Pomati S, Ramolfo P etal. Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2013; 54: 5953-5958.
31. Blanks JC, Torigoe Y, Hinton DR, Blanks RH. Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging 1996; 17: 377-384.
32. Ramrattan RS, van der Schaft TL, Mooy CM, de Brujin WC, Mulder PG, de Jong PT. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol Vis Sci 1994; 35: 2857-2864.
33. Takano T, Han X, Deane R, Zlokovic B, Nedergaard M. Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer's disease. Ann N Y Acad Sci 2007; 1097: 40-50.
34. Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000; 21: 321-330.
35. Cheung CY, Ong YT, Ikram MK etal. Microvascular network alterations in the retina of patients with Alzheimer's disease. Alzheimer Dement 2014; 10: 135-142.
36. Tsai Y, Lu B, Ljubimov AV etal. Ocular changes in TgF344-AD rat model of Alzheimer's disease. Invest Ophthalmol Vis Sci 2014; 55: 523-534.
37. Dorr A, Sahota B, Chinta LV etal. Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer's disease. Brain 2012; 135: 3039-3050.